脑部放疗,上午比下午敏感许多!4 O- f) T# P; [# b* E6 r
; a6 ~8 i7 ^3 z7 x H# W3 M
* M4 m6 b6 Q2 ^+ n: _3 d
Cancer 2011 Jan 15;117(2):414-20. doi: 10.1002/cncr.25423. Epub 2010 Sep 9.
' {' ^) E, L: J: \4 V: {2 ZGamma knife radiosurgery for brain metastasis of nonsmall cell lung cancer: is there a difference in outcome between morning and afternoon treatment?
. }" w R: @7 ?4 _Rahn DA 3rd, Ray DK, Schlesinger DJ, Steiner L, Sheehan JP, O'Quigley JM, Rich T.
7 M9 b) m& N5 K, ?# W3 bSourceDepartment of Radiation Oncology, University of Virginia Health Sciences Center, Charlottesville, Virginia 22908, USA.
2 U. b! q- p4 K6 d/ x" R# o" `, S% A6 N% A4 Y+ K
Abstract
4 ]. E0 g2 D7 K w# u, e1 w; L" UBACKGROUND: Circadian cell-cycle progression causes fluctuating radiosensitivity in many tissues, which could affect clinical outcomes. The purpose of this study was to determine whether outcomes of single-session gamma knife radiosurgery (GKRS) for metastatic nonsmall cell lung cancer (NSCLC) differ based on treatment time.3 [9 u" o' `7 m3 V9 L3 \ |9 u
% a7 M. B$ g8 d* b' p0 k. v
METHODS: Fifty-eight patients received GKRS between 10:00 am and 12:30 pm and 39 patients received GKRS between 12:30 pm and 3:00 pm. The mean peripheral dose was 18.6 Gy. The mean tumor size was 7.3 cm³. Magnetic resonance imaging was used to score local control at 3 months. Cause of death (COD) was categorized as central nervous system (CNS)-related or systemic.0 i: ]7 m( ?) z5 D
2 q& k2 c$ E- h, g7 V6 x) a
RESULTS: Demographic and disease characteristics of the 2 groups were similar. Local control at 3 months was achieved in 97% (35/36) of patients who underwent GKRS early in the day versus 67% (8/12) of patients who underwent GKRS later in the day (chi-square, P = .014). Early GKRS was associated with better survival (median 9.5 months) than late GKRS (median 5 months) (Kaplan-Meier log-rank test, P = .025). Factors contributing to better survival in a Cox regression model included early treatment time (P = .004) and recursive partition analysis class (P < .001). Cause of death in the early treatment group was CNS-related in 6% (3/47) of patients versus 24% (8/34) of patients in the late treatment group (chi-square test, P = .026).$ E% k, f8 J0 z$ x5 n. F
9 N- N5 a4 n+ X. m% `. z
CONCLUSIONS: GKRS for metastatic NSCLC had better local control, better survival, and a lower rate of CNS-related cause of death when given earlier in the day versus later in the day. These retrospective data should encourage future study in brain radiosurgery and non-CNS stereotactic body radiotherapy series.! J. Y; w. r7 x! N4 m% P
0 v" n0 Q# Z4 G- U. U |